Subject of Possible Rule Making: New section within chapter 182-530 WAC, Prescription drugs (outpatient), and other related rules, as appropriate, to establish rules for provider use of the qualified prescription drug monitoring program.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The agency intends to establish rules regarding provider use of the qualified prescription drug monitoring program, as required by Section 5042 of the SUPPORT for Patients and Communities Act (P.L. 115-271), prior to prescribing or dispensing scheduled drugs. During the course of this review, the agency may identify additional related changes in order to improve clarity of update policy.

Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Department of health.

Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Melinda Froud (Rulemaking Questions), P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-1408, fax 360-586-9727, telecommunication[s] relay services (TRS) 711, email Melinda.froud@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Charles Agte (Program Questions), P.O. Box 45502, Olympia, WA 98504-5502, phone 360-725-1301, fax 360-725-2141, TRS 711, email Charles.agte@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.